
Vitamin B3 (nicotinamide) shows early promise for protecting retinal cells in glaucoma
A shared summary says replenishing NAD+ with vitamin B3 may help retinal ganglion cells keep their energy supply and function longer in glaucoma. A 2020 randomized clinical trial of 57 people with glaucoma is cited as human evidence. Evidence is early and not specific to heart health.






